Related Experiment Video
Updated: Jun 28, 2025

06:04
Functional Near-Infrared Spectroscopy Hyperscanning Study in Psychological Counseling
Published on: January 17, 2025
490
Chinese Translation and Validation of the Center for Neurologic Study Lability Scale
Lu Chen1,2, Shan Ye1, Davan Murphy3
1Department of Neurology, Peking University Third Hospital, Haidian District, 49 North Garden Road, Beijing, 100191, China.
Neurology and Therapy
|April 16, 2024
Summary
The Chinese version of the Center for Neurologic Study Lability Scale (CNS-LS) accurately identifies pseudobulbar affect (PBA) in amyotrophic lateral sclerosis (ALS) patients. This validated scale offers a reliable tool for diagnosing PBA in Chinese-speaking ALS populations.
Area of Science:
- Neurology
- Clinical Psychology
Background:
- Pseudobulbar palsy is a frequent, yet often underdiagnosed, symptom in amyotrophic lateral sclerosis (ALS).
- Pseudobulbar affect (PBA) assessment is crucial for patient management.
- The Center for Neurologic Study Lability Scale (CNS-LS) is a validated tool for PBA evaluation.
Purpose of the Study:
- To validate a Chinese version of the CNS-LS for PBA assessment in ALS patients.
- To establish the reliability and criterion validity of the Chinese CNS-LS.
Main Methods:
- Standardized forward-backward translation and cultural adaptation of the CNS-LS.
- Recruitment of 105 ALS patients from Peking University Third Hospital.
- Assessment of reliability using test-retest methods and validity via receiver operating characteristic (ROC) analysis.
Main Results:
- The Chinese CNS-LS demonstrated high test-retest reliability (Spearman's ρ = 0.940) and internal consistency (Cronbach's α = 0.905).
- A score of 12 or higher on the Chinese CNS-LS accurately identified PBA with high sensitivity (0.919) and specificity (0.882).
- ROC analysis confirmed the scale's diagnostic accuracy (Area Under Curve = 0.924).
Conclusions:
- The Chinese version of the CNS-LS is a reliable and valid instrument for assessing PBA in Chinese-speaking ALS patients.
- This validated scale can aid in the clinical diagnosis and research of PBA in this population.
- The CNS-LS facilitates better identification and management of PBA in ALS.

